Replies to post #143972 on Innovation Pharmaceuticals Inc (IPIX)

[scottsmith]

His expertise was brought in for Brilacidin P3

That's news to me.

[BonelessCat]

His expertise was brought in for Phase 2 and design of phase 3. His expertise was brought in to fill the gap created by CTIX acquisition of the Brilacidin platform. There are 3 different drugs and drug platforms in trials . As someone pointed out yesterday his expertise is infectious diseases, while the CMO for CTIX would require familiarity with drug development that Jorgie might not have.

[sox040713]

Dr. J's position was created when Leo acquired PolyMedix. CMO didn't exist when CTIX was founded. One has to look at the working history of the person. He changed jobs several times already. Since he left a giant BP like Pfizer (for whatever reason) before, leaving a small biotech like CTIX (for whatever reason) doesn't seem to be a big deal to me. Besides, isn't Dr. Menon's role as a CSO similar to a CMO?

I'm admittedly a little unnerved by Dr. Jorgensen moving on to another opportunity.